http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000507971-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423 |
| filingDate | 1998-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2000-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2000507971-A |
| titleOfInvention | 3-Amino-1,2-benzisoxazole derivatives, their production and use |
| abstract | (57) [Summary] The present invention relates to LTB-4 (leukotriene-B-4; 5 (S), 12 (R) -dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid). The present invention relates to novel 3-amino-1,2-benzisoxazole derivatives of the formula I, which are antagonists for the receptor, to a process for their preparation and to their use as antagonists for the LTB-4 receptor or as therapeutic agents for osteoporosis. Formula (I) In the formula (I), n is an integer of 3 to 5. |
| priorityDate | 1997-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.